Deep Tech Startups

Palatial converts real objects and environments into physics-accurate, verifiable 3D simulations via an API, generating physics-ready assets at scale to train physical AI and foundation models. Its outputs are formatted for robotics simulators such as NVIDIA Isaac Sim, Newton, and MuJoCo, serving robotics and machine learning teams.

2 investors

Palo Santo is a venture capital firm that invests in neuroscience and mental health companies, focusing on novel CNS therapeutics, next-generation psychedelic therapies, and brain health technologies. The firm targets solutions addressing the innovation gap in mental health treatment and psychiatric disorders.

2 investors

Kraken Robotics is a marine robotics company that develops innovative solutions for underwater exploration and technology applications.

2 investors

Panome Bio provides metabolomics, proteomics, and multi-omics integration workflows along with a computational platform that analyzes and integrates diverse biological data types. It serves life science and biotechnology researchers looking to identify biomarkers and generate research insights.

2 investors

Pantograph is a research lab developing generally intelligent robots using scalable methods. Its work includes Pan 1, a foundation model trained on Minecraft gameplay videos that can accomplish goals it was not explicitly trained on.

2 investors

Paradigma builds infrastructure for autonomous research, enabling automated research workflows and operations.

2 investors

Parallel Flight develops heavy-lift unmanned aerial vehicle (drone) technology for applications such as aerial firefighting and industrial operations. The company builds hardware, systems, and control software for long-endurance heavy-payload drones.

2 investors

Parallel Robotics is an engineering R&D firm specializing in mechatronics, robotics, and mechanical design. It offers full-stack engineering services in these domains.

2 investors

ParaNetics develops electric motors based on a patented ParaNetic magnetic field technology that utilizes both sides of rotor and stator magnetic fields to achieve higher power output and efficiency. The company targets electric aircraft, underwater submersibles, and other emerging propulsion markets through a licensing and royalty business model.

2 investors

ParityQC develops architecture blueprints and an operating system for scalable quantum computers, covering applications from optimization on NISQ devices to error-corrected, general-purpose quantum computing. Its co-development approach combines quantum hardware and software, including its Parity Twine technology for implementing quantum algorithms.

2 investors

Parry builds integrated mission systems combining software, hardware, and AI-enabled autonomy that operate across platforms and environments without requiring custom integration. The company serves warfighters and defense organizations by delivering reliable, coordinated systems for tactical edge operations.

2 investors

PathoQuest develops iDTECT, a platform of Next Generation Sequencing (NGS) assays for biopharmaceutical quality control, offering animal-free viral safety testing and genetic characterization of cell banks and biologics. The company was acquired by Charles River Labs to expand its end-to-end biologics testing portfolio.

2 investors

PathoScan provides portable, field-deployable pathogen detection technology for agronomists and growers, enabling rapid diagnosis of crop diseases within hours rather than days.

2 investors

Pearl Semiconductor develops timing products, including oscillators and clock generators, using analog/mixed-signal and CMOS-based semiconductor technology. Spun out of Si-Ware Systems in 2020, the company operates in the timing segment of the semiconductor industry with an offshore design center in Malaysia.

2 investors

PEP-Therapy develops peptide-based therapeutic candidates for oncology, with a lead product in clinical trials targeting solid tumors including ovarian cancer and pancreatic cancer. The company uses an intracellular delivery technology platform to deliver peptides that restore apoptosis in cancer cells.

2 investors

Peptinovo develops PALM™, a targeted drug-delivery platform that encapsulates chemotherapy drugs to deliver them directly to cancer cells while sparing healthy tissue, reducing side effects and enabling higher therapeutic doses. The technology mimics HDL cholesterol carriers that cancer cells naturally uptake, allowing selective destruction of tumors with improved safety profiles.

2 investors

Peraso develops mmWave silicon chips and modules used in applications including 5G fixed wireless access, tactical communications, wireless video streaming, and AR/VR/XR. The company designs and ships high-volume mmWave semiconductor devices for telecom, defense, and consumer wireless applications.

2 investors

Perceptyne builds semi-humanoid robots with a 7-DOF arm that combine vision, force, and tactile sensing with physical AI to automate repetitive industrial workflows such as picking, placing, bolting, inspecting, and assembly. The company targets manufacturers and industrial operations, developing its robots ground-up in India.

2 investors

Perciv AI builds radar-based perception kits equipped with detection, classification, and localization models for robots and autonomous machines operating in adverse conditions such as rain, fog, and darkness. Its turnkey systems target physical AI applications across agriculture, logistics, construction, and defense, offering LiDAR-like performance at lower cost.

2 investors

Peregrine is a global life science venture capital fund that invests in healthcare companies through strategic synergistic investments. The firm partners with entrepreneurs and established healthcare institutions to develop innovations that improve health outcomes and healthcare economics.

2 investors

Perfuze develops medical devices for the treatment of acute ischemic stroke, focused on addressing unmet clinical needs in mechanical thrombectomy. The company is a medical technology firm based in Ireland with clinical partnerships in the US and Europe.

2 investors

Perimeter Medical Imaging AI develops ultra-high resolution imaging tools and AI software to help surgeons assess tumor margins during cancer surgery in real-time. The Toronto-based company aims to reduce the need for repeat surgeries by enabling surgeons to detect remaining cancer cells using proprietary Optical Coherence Tomography technology.

2 investors

Periotherapia develops antibody-based therapeutics targeting pathological periostin in the stromal environment to treat refractory diseases including cancer, diabetic retinopathy, and heart disease. The company, spun out from Osaka University, is conducting clinical trials for HER2-negative triple-negative breast cancer with support from Japan's AMED program.

2 investors

PerkinElmer is a scientific instrument and technology company that provides analytical tools and services for research, diagnostics, and life sciences applications. The company operates globally with a focus on enabling scientific discovery and sustainability.

2 investors